Co-Authors
This is a "connection" page, showing publications co-authored by Monica Gandhi and Matthew Spinelli.
Connection Strength
3.669
-
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' reply. Lancet Infect Dis. 2021 07; 21(7):915-916.
Score: 0.940
-
Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity. Lancet Infect Dis. 2021 09; 21(9):e296-e301.
Score: 0.931
-
Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. AIDS. 2020 12 01; 34(15):2328-2331.
Score: 0.916
-
Tenofovir-based PrEP for COVID-19: an untapped opportunity? AIDS. 2021 07 15; 35(9):1509-1511.
Score: 0.239
-
SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV. 2021 06; 8(6):e334-e341.
Score: 0.236
-
The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS. 2021 01; 16(1):63-73.
Score: 0.230
-
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518.
Score: 0.060
-
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Sci Adv. 2021 Jul; 7(31).
Score: 0.060
-
Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV. J Telemed Telecare. 2020 Dec 20; 1357633X20976036.
Score: 0.057